NERVGEN PHARMA CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.33 CAD | +7.87% |
|
+10.43% | -13.70% |
| Apr. 17 | NervGen Reports FY 2023 Net Loss of $0.38 Per Share, Provides Operations Update | MT |
| Apr. 17 | NervGen Pharma Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Quotes 5-day view
Delayed Quote Toronto S.E.| 2024-04-30 | 2024-05-01 | 2024-05-02 | 2024-05-03 | |
|---|---|---|---|---|
| Last | 2.1 $ | 2.05 $ | 2.16 $ | 2.33 $ |
| Volume | 140 868 | 58 205 | 188 939 | 261 878 |
| Change | +1.94% | -2.38% | +5.37% | +7.87% |
| Opening | 2.07 | 2.13 | 2.07 | 2.22 |
| High | 2.19 | 2.13 | 2.22 | 2.35 |
| Low | 2.04 | 2.04 | 2.07 | 2.18 |
Performance
| 1 day | +7.87% | ||
| 1 week | +10.43% | ||
| Current month | +10.95% | ||
| 1 month | +2.19% | ||
| 3 months | -33.24% | ||
| 6 months | +29.44% | ||
| Current year | -13.70% | ||
| 1 year | +42.94% | ||
| 3 years | +33.91% | ||
| 5 years | +36.26% |
Volumes
marketsDaily volume
261 878
Estimated daily volume
261 878
Avg. Volume 20 sessions
99 618
Daily volume ratio
2.63
Avg. Volume 20 sessions CAD
232 109.94
Avg. Volume 20 sessions USD
169 486.68
Record volume 1
658 918
Record volume 2
448 741
Record volume 3
420 965
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (CAD)
119 071 452
Capitalization (USD)
119 071 452
Net sales ()
0
Free-Float
77.07 %
Free-Float capitalization (CAD)
91 769 243
Free-Float capitalization (USD)
91 769 243
Average Daily Capital Traded
0.19%
Highs and lows
1 week
2.04
2.35
1 month
1.872.35
Current year
1.873.98
1 year
1.553.98
3 years
1.263.98
5 years
0.803.98
10 years
0.803.98
Indicators
Moving average 5 days
2.14
Moving average 20 days
2.10
Moving average 50 days
2.51
Moving average 100 days
2.58
Price spread / (MMA5)
-8.15%
Price spread / (MMA20)
-9.74%
Price spread / (MMA50)
+7.65%
Price spread / (MMA100)
+10.66%
STIM
RSI 9 days
52.84
RSI 14 days
47.71
Sector Comparison - Other Biotechnology & Medical Research
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +7.87% | +10.43% | -13.70% | +42.94% | 119M | ||
| -0.47% | +15.77% | +25.69% | -6.95% | 47.9B | ||
| +1.09% | -1.55% | +46.90% | -10.54% | 41.42B | ||
| +0.55% | -4.90% | -3.46% | +21.13% | 40.7B | ||
| +0.80% | +7.02% | -6.20% | +15.95% | 28.92B | ||
| +2.64% | +0.23% | +9.17% | +68.75% | 25.55B | ||
| +1.34% | +6.29% | -20.42% | -25.83% | 19.27B | ||
| +2.24% | +20.65% | +0.17% | -8.02% | 12.15B | ||
| +0.38% | -0.85% | +28.07% | +91.32% | 12.14B | ||
| +1.56% | +1.94% | -1.24% | +23.22% | 11.99B | ||
| +1.65% | +12.21% | +19.33% | +21.64% | 11.64B | ||
| +0.70% | +3.19% | -4.01% | -9.45% | 9.53B | ||
| +2.58% | +11.79% | +40.17% | +65.91% | 6.85B | ||
| +0.18% | +15.26% | +16.21% | +83.51% | 6.71B | ||
| +1.64% | -0.92% | +23.62% | -19.41% | 6.66B | ||
| -0.94% | +2.44% | +7.53% | -33.84% | 6.6B | ||
| Average | +1.49% | +6.82% | +10.49% | +20.02% | ||
| Weighted average by Cap. | +0.91% | +5.28% | +13.18% | +13.63% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
a3f381ce.h30DaATQywY-GaBoXXI5w2HllSWKiBQyrL1gHfMWIxA.9TFUXn2flFRXePMDKBkK8zW_w2fO0FZFmo86aJFREXzeTnpQbbmTNWRQ0w
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 03:59:59 pm | 2.33 | 300 | 260,900 |
| 03:59:59 pm | 2.32 | 500 | 260,600 |
| 03:59:59 pm | 2.32 | 5,700 | 260,100 |
| 03:59:58 pm | 2.3 | 800 | 254,400 |
| 03:56:33 pm | 2.31 | 100 | 253,600 |
| 03:56:26 pm | 2.31 | 100 | 253,500 |
| 03:54:31 pm | 2.31 | 100 | 253,400 |
| 03:51:37 pm | 2.31 | 100 | 253,300 |
| 03:51:27 pm | 2.31 | 100 | 253,200 |
| 03:46:41 pm | 2.32 | 2,900 | 253,100 |
Monthly variations
Annual change
| 2024 | -13.70% | ||
| 2023 | +68.75% | ||
| 2022 | -41.39% | ||
| 2021 | +22.42% | ||
| 2020 | +13.78% | ||
| 2019 | +12.64% |
- Stock Market
- Equities
- NGEN Stock
- Quotes NervGen Pharma Corp.
